Skip to Content

Mono-Vacc Test (OT) (tuberculin purified protein derivative) Drug Interactions

A total of 475 drugs are known to interact with Mono-Vacc Test (OT) (tuberculin purified protein derivative).

  • 475 moderate drug interactions

Check for interactions with Mono-Vacc Test (OT) (tuberculin purified protein derivative)

Type in a drug name and select a drug from the list.

Medications known to interact with Mono-Vacc Test (OT) (tuberculin purified protein derivative)

A B C D E F G H I L M N O P R S T U V Y Z

A
B
C
D
E
F
G
H
I
L
  • leflunomide (Arava)
  • lenalidomide (Revlimid)
  • letrozole / ribociclib (Kisqali Femara Co-Pack)
  • levamisole (Ergamisol)
  • levocetirizine (Xyzal, Xyzal Allergy 24HR, Levrix)
  • lomustine (Gleostine, CeeNU, CCNSB Capsules)
  • loratadine (Claritin, Alavert, Allergy Relief Tablets, Claritin 24 Hour Allergy, Claritin Reditabs, Loratadine Reditab, Wal-itin, Help I Have Allergies, Children's Claritin Allergy, Allergy Relief 24 Hour, Children's Allergy Relief 24 Hour, Vicks QlearQuil All Day & All Night 24 Hour Allergy Relief, ohm Allergy Relief, Clear-Atadine, Claritin Hives Relief, Dimetapp Children's ND Non-Drowsy Allergy, Clear-Atadine Children's, Bactimicina Allergy, Tavist ND)
  • loratadine / pseudoephedrine (Claritin-D, Loratadine-D 24 Hour, Claritin-D 24 Hour, Loratadine-D 12 Hour, AllerClear D-24 Hour, Claritin-D 12 Hour, Clear-Atadine-D, Alavert D-12 Hour Allergy and Sinus, Allergy Relief D12, Leader Allergy Relief D-24, Allergy & Congestion Relief, Allergy Relief D 24 Hour)
  • lutetium lu 177 dotatate (Lutathera)
  • lymphocyte immune globulin, anti-thy (equine) (Atgam)
M
N
O
P
R
S
T
U
V
Y
Z

More about Mono-Vacc Test (OT) (tuberculin purified protein derivative)

Related treatment guides

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide